Literature DB >> 20357825

MSK1 activation in acute myeloid leukemia cells with FLT3 mutations.

T Odgerel, J Kikuchi, T Wada, R Shimizu, Y Kano, Y Furukawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357825     DOI: 10.1038/leu.2010.48

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Aminoisoquinoline benzamides, FLT3 and Src-family kinase inhibitors, potently inhibit proliferation of acute myeloid leukemia cell lines.

Authors:  Elizabeth Larocque; N Naganna; Xiaochu Ma; Clement Opoku-Temeng; Brandon Carter-Cooper; Gaurav Chopra; Rena G Lapidus; Herman O Sintim
Journal:  Future Med Chem       Date:  2017-05-11       Impact factor: 3.808

2.  Electrophilic fragment-based design of reversible covalent kinase inhibitors.

Authors:  Rand M Miller; Ville O Paavilainen; Shyam Krishnan; Iana M Serafimova; Jack Taunton
Journal:  J Am Chem Soc       Date:  2013-03-29       Impact factor: 15.419

3.  Chronic growth factor receptor signaling and lineage inappropriate gene expression in AML: the polycomb connection.

Authors:  Debleena Ray; So Yeon Kwon; Anetta Ptasinska; Constanze Bonifer
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

4.  Mitogen- and Stress-Activated Protein Kinase 1 Regulates Status Epilepticus-Evoked Cell Death in the Hippocampus.

Authors:  Yun-Sik Choi; Paul Horning; Sydney Aten; Kate Karelina; Diego Alzate-Correa; J Simon C Arthur; Kari R Hoyt; Karl Obrietan
Journal:  ASN Neuro       Date:  2017 Sep-Oct       Impact factor: 4.146

5.  Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking.

Authors:  Md Lutfur Rahman; Toshinori Hyodo; Sivasundaram Karnan; Akinobu Ota; Muhammad Nazmul Hasan; Yuko Mihara; Md Wahiduzzaman; Shinobu Tsuzuki; Yoshitaka Hosokawa; Hiroyuki Konishi
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

6.  Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2.

Authors:  Elisabeth Lang; Rosi Bissinger; Abul Fajol; Madhuri S Salker; Yogesh Singh; Christine Zelenak; Mehrdad Ghashghaeinia; Shuchen Gu; Kashif Jilani; Adrian Lupescu; Kathleen M S E Reyskens; Teresa F Ackermann; Michael Föller; Erwin Schleicher; William P Sheffield; J Simon C Arthur; Florian Lang; Syed M Qadri
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

7.  Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.

Authors:  A B Lee-Sherick; K M Eisenman; S Sather; A McGranahan; P M Armistead; C S McGary; S A Hunsucker; J Schlegel; H Martinson; C Cannon; A K Keating; H S Earp; X Liang; D DeRyckere; D K Graham
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

8.  Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice.

Authors:  N Naganna; Clement Opoku-Temeng; Eun Yong Choi; Elizabeth Larocque; Elizabeth T Chang; Brandon A Carter-Cooper; Modi Wang; Sandra E Torregrosa-Allen; Bennett D Elzey; Rena G Lapidus; Herman O Sintim
Journal:  EBioMedicine       Date:  2019-01-25       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.